Cargando…
Epigenetic Regulations in Diabetic Nephropathy
Diabetic nephropathy (DN) is a chronic complication of diabetes and the most common cause of end-stage kidney disease. It has been reported that multiple factors are involved in the pathogenesis of DN, while the molecular mechanisms that lead to DN are still not fully understood. Numerous risk facto...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5376412/ https://www.ncbi.nlm.nih.gov/pubmed/28401169 http://dx.doi.org/10.1155/2017/7805058 |
_version_ | 1782519152426090496 |
---|---|
author | Lu, Zeyuan Liu, Na Wang, Feng |
author_facet | Lu, Zeyuan Liu, Na Wang, Feng |
author_sort | Lu, Zeyuan |
collection | PubMed |
description | Diabetic nephropathy (DN) is a chronic complication of diabetes and the most common cause of end-stage kidney disease. It has been reported that multiple factors are involved in the pathogenesis of DN, while the molecular mechanisms that lead to DN are still not fully understood. Numerous risk factors for the development of diabetic nephropathy have been proposed, including ethnicity and inherited genetic differences. Recently, with the development of high-throughput technologies, there is emerging evidence that suggests the important role of epigenetic mechanisms in the pathogenesis of DN. Epigenetic regulations, including DNA methylation, noncoding RNAs, and histone modifications, play a pivotal role in DN pathogenesis by a second layer of gene regulation. All these findings can contribute to developing novel therapies for DN. |
format | Online Article Text |
id | pubmed-5376412 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Hindawi |
record_format | MEDLINE/PubMed |
spelling | pubmed-53764122017-04-11 Epigenetic Regulations in Diabetic Nephropathy Lu, Zeyuan Liu, Na Wang, Feng J Diabetes Res Review Article Diabetic nephropathy (DN) is a chronic complication of diabetes and the most common cause of end-stage kidney disease. It has been reported that multiple factors are involved in the pathogenesis of DN, while the molecular mechanisms that lead to DN are still not fully understood. Numerous risk factors for the development of diabetic nephropathy have been proposed, including ethnicity and inherited genetic differences. Recently, with the development of high-throughput technologies, there is emerging evidence that suggests the important role of epigenetic mechanisms in the pathogenesis of DN. Epigenetic regulations, including DNA methylation, noncoding RNAs, and histone modifications, play a pivotal role in DN pathogenesis by a second layer of gene regulation. All these findings can contribute to developing novel therapies for DN. Hindawi 2017 2017-03-19 /pmc/articles/PMC5376412/ /pubmed/28401169 http://dx.doi.org/10.1155/2017/7805058 Text en Copyright © 2017 Zeyuan Lu et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Article Lu, Zeyuan Liu, Na Wang, Feng Epigenetic Regulations in Diabetic Nephropathy |
title | Epigenetic Regulations in Diabetic Nephropathy |
title_full | Epigenetic Regulations in Diabetic Nephropathy |
title_fullStr | Epigenetic Regulations in Diabetic Nephropathy |
title_full_unstemmed | Epigenetic Regulations in Diabetic Nephropathy |
title_short | Epigenetic Regulations in Diabetic Nephropathy |
title_sort | epigenetic regulations in diabetic nephropathy |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5376412/ https://www.ncbi.nlm.nih.gov/pubmed/28401169 http://dx.doi.org/10.1155/2017/7805058 |
work_keys_str_mv | AT luzeyuan epigeneticregulationsindiabeticnephropathy AT liuna epigeneticregulationsindiabeticnephropathy AT wangfeng epigeneticregulationsindiabeticnephropathy |